129 related articles for article (PubMed ID: 14615147)
41. Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine.
Kerkhofs P; Renjifo X; Toussaint JF; Letellier C; Vanopdenbosch E; Wellemans G
Vet Rec; 2003 May; 152(22):681-6. PubMed ID: 12803395
[TBL] [Abstract][Full Text] [Related]
42. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
Strube W; Auer S; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
Vet Microbiol; 1996 Nov; 53(1-2):181-9. PubMed ID: 9011010
[TBL] [Abstract][Full Text] [Related]
43. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.
Gogev S; de Fays K; Versali MF; Gautier S; Thiry E
Vaccine; 2004 May; 22(15-16):1946-53. PubMed ID: 15121307
[TBL] [Abstract][Full Text] [Related]
44. Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.
DesCôteaux L; Cécyre D; Elsener J; Beauchamp G
Can Vet J; 2003 Oct; 44(10):816-21. PubMed ID: 14601677
[TBL] [Abstract][Full Text] [Related]
45. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
Patel JR; Shilleto RW
Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
[TBL] [Abstract][Full Text] [Related]
46. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant.
Chowdhury SI; Ross CS; Lee BJ; Hall V; Chu HJ
Am J Vet Res; 1999 Feb; 60(2):227-32. PubMed ID: 10048557
[TBL] [Abstract][Full Text] [Related]
47. Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity.
Pérez Filgueira DM; Zamorano PI; Domínguez MG; Taboga O; Del Médico Zajac MP; Puntel M; Romera SA; Morris TJ; Borca MV; Sadir AM
Vaccine; 2003 Oct; 21(27-30):4201-9. PubMed ID: 14505899
[TBL] [Abstract][Full Text] [Related]
48. Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency.
Lemaire M; Weynants V; Godfroid J; Schynts F; Meyer G; Letesson JJ; Thiry E
J Clin Microbiol; 2000 May; 38(5):1885-94. PubMed ID: 10790117
[TBL] [Abstract][Full Text] [Related]
49. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.
Taylor G; Rijsewijk FA; Thomas LH; Wyld SG; Gaddum RM; Cook RS; Morrison WI; Hensen E; van Oirschot JT; Keil G
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1759-67. PubMed ID: 9680140
[TBL] [Abstract][Full Text] [Related]
50. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.
van Drunen Littel-van den Hurk S; Myers D; Doig PA; Karvonen B; Habermehl M; Babiuk LA; Jelinski M; Van Donkersgoed J; Schlesinger K; Rinehart C
Can J Vet Res; 2001 Apr; 65(2):81-8. PubMed ID: 11346260
[TBL] [Abstract][Full Text] [Related]
51. Specific passive immunity reduces the excretion of glycoprotein E-negative bovine herpesvirus type 1 vaccine strain in calves.
Lemaire M; Hanon E; Schynts F; Meyer G; Thiry E
Vaccine; 2000 Dec; 19(9-10):1013-7. PubMed ID: 11137234
[TBL] [Abstract][Full Text] [Related]
52. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine.
Kaashoek MJ; van Oirschot JT
Vet Microbiol; 1996 Nov; 53(1-2):191-7. PubMed ID: 9011011
[TBL] [Abstract][Full Text] [Related]
53. Immune response to infectious bovine rhinotracheitis virus (IBRV) following natural infection or vaccination by intranasally or parenterally administered vaccines.
Todd JD
Dev Biol Stand; 1975; 28():526-9. PubMed ID: 165128
[TBL] [Abstract][Full Text] [Related]
54. High-level expression of biologically active bovine alpha interferon by Bovine herpesvirus 1 interferes only marginally with recombinant virus replication in vitro.
Höhle C; Karger A; König P; Giesow K; Keil GM
J Gen Virol; 2005 Oct; 86(Pt 10):2685-2695. PubMed ID: 16186221
[TBL] [Abstract][Full Text] [Related]
55. Attempted reactivation of latent bovine herpesvirus 1 infection in calves by infection with ruminant pestiviruses.
Edwards S; Roeder PL
Vet Microbiol; 1983 Nov; 8(6):563-9. PubMed ID: 6318422
[TBL] [Abstract][Full Text] [Related]
56. Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection.
Jericho KW; Yates WD; Babiuk LA
Am J Vet Res; 1982 Oct; 43(10):1776-80. PubMed ID: 6183996
[TBL] [Abstract][Full Text] [Related]
57. Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1.
Toussaint JF; Letellier C; Paquet D; Dispas M; Kerkhofs P
Vaccine; 2005 Oct; 23(43):5073-81. PubMed ID: 16024138
[TBL] [Abstract][Full Text] [Related]
58. Immunology of bovine herpesvirus 1 infection.
Babiuk LA; van Drunen Littel-van den Hurk S; Tikoo SK
Vet Microbiol; 1996 Nov; 53(1-2):31-42. PubMed ID: 9010996
[TBL] [Abstract][Full Text] [Related]
59. Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines.
van Drunen Littel-van den Hurk S; Tikoo SK; van den Hurk JV; Babiuk LA; Van Donkersgoed J
Vaccine; 1997 Jan; 15(1):36-44. PubMed ID: 9041664
[TBL] [Abstract][Full Text] [Related]
60. Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine.
Belknap EB; Walters LM; Kelling C; Ayers VK; Norris J; McMillen J; Hayhow C; Cochran M; Reddy DN; Wright J; Collins JK
Vaccine; 1999 May; 17(18):2297-305. PubMed ID: 10403598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
